Dolutegravir As Second-Line Treatment Results In Drug Exposure Levels Comparable When Taken With Versus Without Food In Children With HIV, Research Suggests

Infectious Disease Advisor (7/17, Kuhns) reports, “Dolutegravir as second-line treatment for children with HIV infection results in comparable drug exposure levels when taken with vs without food, according to study findings.” The results were published i...